
NYSEHealthcareMedical - Diagnostics & Research
ข้อมูลล่าสุด
US$662.06
+US$5.48 · +0.83%
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
ราคาปิดก่อนหน้า
US$662.06
+US$5.48 · +0.83%
ก่อนเปิดตลาด
US$661.5
−US$0.56 · -0.08%
8 ต.ค. 4:30 ET
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
ช่วงราคารายวัน
ปัจจุบัน US$662.06
ช่วง 52 สัปดาห์
ปัจจุบัน US$662.06
เวลาในวันใช้เขตเวลาET ข้อมูลตลาดอาจล่าช้า
คะแนน GoAI
ซื้อ
มูลค่า
77
ต่ำกว่ามูลค่า
ความเชื่อมั่น
66
เชิงบวก
ความเสี่ยง
32
ความเสี่ยงปานกลาง
โมเมนตัม
53
เป็นกลาง
งานวิจัย GoAI ฉบับเต็ม
ดูข้อมูลสนับสนุน ปัจจัยหนุน และความเสี่ยงในเชิงลึก
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
ช่วงราคารายวัน
ปัจจุบัน US$662.06
ช่วง 52 สัปดาห์
ปัจจุบัน US$662.06
อัตรากำไรที่รายงานในช่วงเวลาที่มีอยู่
รายได้
รายได้จากการดำเนินงาน
รายได้สุทธิ
| รายการ (USD) | ปีงบประมาณ 2025 | ปีงบประมาณ 2024 | ปีงบประมาณ 2023 | ปีงบประมาณ 2022 | ปีงบประมาณ 2021 |
|---|---|---|---|---|---|
| รายได้ | 44.56B USD | 42.88B USD | 42.86B USD | 44.92B USD | 39.21B USD |
| ต้นทุนสินค้าขาย | 26.32B USD | 25.15B USD | 25.66B USD | 25.9B USD | 19.58B USD |
| กำไรขั้นต้น | 18.24B USD | 17.73B USD | 17.19B USD | 19.01B USD | 19.63B USD |
| การวิจัยและพัฒนา | 1.4B USD | 1.39B USD | 1.34B USD | 1.47B USD | 1.41B USD |
| การขาย ทั่วไป และธุรการ | 8.73B USD | 8.68B USD | 8.41B USD | 9.02B USD | 7.91B USD |
| ค่าใช้จ่ายในการดำเนินงาน | 10.13B USD | 10.07B USD | 9.75B USD | 10.49B USD | 9.32B USD |
| รายได้ดอกเบี้ย | 993M USD | 1.08B USD | 879M USD | 272M USD | 43M USD |
| ดอกเบี้ยจ่าย | 1.42B USD | 1.65B USD | 1.49B USD | 726M USD | 536M USD |
| ค่าเสื่อมราคาและค่าตัดจำหน่าย | 2.78B USD | 3.11B USD | 3.41B USD | 3.38B USD | 2.59B USD |
| รายได้จากการดำเนินงาน | 8.11B USD | 7.66B USD | 7.45B USD | 8.53B USD | 10.32B USD |
| รายได้สุทธิ | 6.74B USD | 6.34B USD | 6B USD | 6.95B USD | 7.73B USD |
ข้อเท็จจริงของบริษัทได้รับการปรับปรุง 8 ต.ค. 2569.
ผลประกอบการล่าสุดที่ประกาศ
ผลประกอบการล่าสุดที่ประกาศ
ประมาณการของนักวิเคราะห์ภายนอกอาจเปลี่ยนแปลงและไม่ใช่คำแนะนำของ GoAI
เป้าหมายเฉลี่ย
US$640.54
โอกาสปรับลง 3.25%กองทุนซื้อขายแลกเปลี่ยนที่รายงานความเสี่ยงต่อหุ้นนี้
State Street SPDR S&P 500 ETF1557.T467.3B0.36%129.41T JPY0.09%¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI7.29B0.31%2.3T USD0.03%US$381.03-0.40%
Vanguard S&P 500 ETFVOO6.09B0.35%1.8T USD0.03%US$714.34-0.26%
iShares Core S&P 500 ETFIVV3.23B0.36%899.63B USD0.03%US$780.58-0.25%
State Street SPDR S&P 500 ETFSPY2.95B0.36%819.04B USD0.09%US$777.22-0.24%
Vanguard Morningstar Value ETFVTV2.19B0.83%262.4B USD0.03%US$218.21-0.37%
State Street Health Care Select Sector SPDR ETFXLV1.73B4.00%43.11B USD0.08%US$168.81+1.03%
Vanguard Health Care ETFVHT699.87M3.17%22B USD0.09%US$315.31+0.78%
State Street SPDR S&P 500 ETF1557.T
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard S&P 500 ETFVOO
iShares Core S&P 500 ETFIVV
State Street SPDR S&P 500 ETFSPY
Vanguard Morningstar Value ETFVTV
State Street Health Care Select Sector SPDR ETFXLV
Vanguard Health Care ETFVHTเนื้อหาที่สร้างโดย AI และข้อมูลตลาดที่ล่าช้ามีไว้เพื่อให้ข้อมูลและการศึกษาเท่านั้น ไม่ใช่คำแนะนำการลงทุน